Approved APIs in focus
Pharmaceutical Substances – a one-stop source of information relating to the industrial synthesis and commercial applications of every licensed drug of significance. The structure-searchable resource is an ideal tool for researchers, process chemists and for teaching in the field of medicinal and pharmaceutical chemistry.
• Full synthetic route for the industrial manufacture of each drug elucidated from the patent literature • Unique source of reactions that perform on an industrial scale • Overview of the pharmaceutical industry from a synthetic chemist's perspective • Insights into a therapeutic area and chemically related substances
• First determination of the market size & competition for an API - essential for development of new and generic pharmaceuticals • Source of markets for synthesis intermediates, ingredients, and enzymes • Patent information including approval date and expiration • Comprehensive coverage of older APIs and substances approved worldwide • Merger and acquisition tracking ensuring that vendor information is up-to-date in a rapidly changing industry
• Capability to search for marketed drugs relating to a structure or reaction • A rapid overview of a therapeutic area or chemically related substances • Industrial synthetic routes discerned from complex patent descriptions • Insights into industrial processes and toxicity issues • Commercial information such as trade names and vendors/manufacturers for six world markets • Concise records ideal for hand-outs and quick reference
Download our Brochure
By clicking the „Submit"-Button, you hereby agree to our Privacy Policy.
When requesting an institutional trial to the Pharmaceutical Substances platform, you consent to be contacted by a Thieme staff member within six weeks (via e-mail, telephone, or mail) to set up your institutional trial and answer questions or clarify any outstanding issues that you might have. You also agree to receive e-mails with relevant information regarding Pharmaceutical Substances for the duration of your access. You have the right to withdraw this consent at any time, by sending an e-mail to customerservice@thieme.de. Withdrawing your consent will not affect the outcome of your trial access.